Cargando…

Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa

Pseudomonas aeruginosa is an opportunistic nosocomial pathogen associated with high morbidity and mortality rates. Combination of antibiotics has been found to combat multi-drug resistant or extensively drug resistance P. aeruginosa. In this study we investigate the in vitro and in vivo effect of am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farhan, Sara Mahmoud, Raafat, Mohamed, Abourehab, Mohammed A. S., Abd El-Baky, Rehab Mahmoud, Abdalla, Salah, EL-Gendy, Ahmed Osama, Azmy, Ahmed Farag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615098/ https://www.ncbi.nlm.nih.gov/pubmed/34827367 http://dx.doi.org/10.3390/antibiotics10111429

Ejemplares similares

In Vitro and In Vivo Effect of Amikacin and Imipenem Combinations against Multidrug-Resistant E. coli
por: Farhan, Sara Mahmoud, et al.
Publicado: (2022)

Morphological and Bactericidal Effects of Amikacin, Meropenem and Imipenem on Pseudomonas aeruginosa
por: Moghoofei, Mohsen, et al.
Publicado: (2015)

Comparative Investigation into the Roles of Imipenem:Cyclodextrin Complexation and Antibiotic Combination in Combatting Antimicrobial Resistance in Gram-Negative Bacteria
por: Farhan, Sara Mahmoud, et al.
Publicado: (2023)

Effect of Titanium Dioxide Nanoparticles on the Expression of Efflux Pump and Quorum-Sensing Genes in MDR Pseudomonas aeruginosa Isolates
por: Ahmed, Fatma Y., et al.
Publicado: (2021)

Prevalence of Quorum Sensing and Virulence Factor Genes Among Pseudomonas aeruginosa Isolated from Patients Suffering from Different Infections and Their Association with Antimicrobial Resistance
por: Ghanem, Shimaa M, et al.
Publicado: (2023)

Virulence profiles of some Pseudomonas aeruginosa clinical isolates and their association with the suppression of Candida growth in polymicrobial infections
por: Abd El-Baky, Rehab Mahmoud, et al.
Publicado: (2020)

Imipenem Resistant Pseudomonas aeruginosa: The fall of the final quarterback
por: Ameen, Nadya, et al.
Publicado: (2015)

Genomic Characterization of Imipenem- and Imipenem-Relebactam-Resistant Clinical Isolates of Pseudomonas aeruginosa
por: López-Pérez, Mario, et al.
Publicado: (2021)

Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa
por: Xu, Ye, et al.
Publicado: (2020)

Comparative Study of Antibacterial Effects of Titanium Dioxide Nanoparticles Alone and in Combination with Antibiotics on MDR Pseudomonas aeruginosa Strains
por: Ahmed, Fatma Y, et al.
Publicado: (2020)

Antimicrobial resistance pattern and molecular genetic distribution of metallo-β-lactamases producing Pseudomonas aeruginosa isolated from hospitals in Minia, Egypt
por: Farhan, Sara M, et al.
Publicado: (2019)

Imipenem-Resistant Pseudomonas aeruginosa: Risk Factors for Nosocomial Infections
por: Onguru, Pinar, et al.
Publicado: (2008)

Glucose-Potentiated Amikacin Killing of Cefoperazone/Sulbactam Resistant Pseudomonas aeruginosa
por: Tang, Xi-kang, et al.
Publicado: (2022)

The comparative effects of erythromycin and amikacin on acute respiratory Pseudomonas aeruginosa infection
por: Yazdanian, Mohsen, et al.
Publicado: (2022)

Phenotypic Detection of Metallo-β-Lactamase in Imipenem-Resistant Pseudomonas aeruginosa
por: Khosravi, Yalda, et al.
Publicado: (2012)

Imipenem Resistance Mediated by bla(OXA-913) Gene in Pseudomonas aeruginosa
por: Moon, Dong-Chan, et al.
Publicado: (2021)

Efficacy of intraventricular amikacin treatment in pan-resistant Pseudomonas aeruginosa postsurgical meningitis
por: Molinaro, Mariadelfina, et al.
Publicado: (2018)

Impact of the Epithelial Lining Fluid Milieu on Amikacin Pharmacodynamics Against Pseudomonas aeruginosa
por: Heffernan, Aaron J., et al.
Publicado: (2021)

The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection
por: Wang, Yuhang, et al.
Publicado: (2022)

Corrigendum to “Phenotypic Detection of Metallo-β-Lactamase in Imipenem-Resistant Pseudomonas aeruginosa”
por: Khosravi, Yalda, et al.
Publicado: (2016)

Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
por: Dahdouh, E., et al.
Publicado: (2014)

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa
por: Young, Katherine, et al.
Publicado: (2019)

Molecular Epidemiology and Mechanisms of High-Level Resistance to Meropenem and Imipenem in Pseudomonas aeruginosa
por: Hassuna, Noha Anwar, et al.
Publicado: (2020)

rpoS-mutation variants are selected in Pseudomonas aeruginosa biofilms under imipenem pressure
por: Duan, Xiangke, et al.
Publicado: (2021)

Antimicrobial Activity of Silver-Treated Bacteria against Other Multi-Drug Resistant Pathogens in Their Environment
por: Mohamed, Doaa Safwat, et al.
Publicado: (2020)

Efficacy and durability of bovine virus diarrhea (BVD) virus killed vaccine adjuvanted with monolaurin
por: Abd El Fadeel, Maha Raafat, et al.
Publicado: (2022)

Tobramycin and Amikacin Delay Adhesion and Microcolony Formation in Pseudomonas aeruginosa Cystic Fibrosis Isolates
por: Olivares, Elodie, et al.
Publicado: (2017)

The predictive potential of different molecular markers linked to amikacin susceptibility phenotypes in Pseudomonas aeruginosa
por: Nageeb, Wedad M., et al.
Publicado: (2022)

Effect of Combination Therapy of Ceftazidime/Amikacin and Monotherapy with Imipenem on the Treatment of Fever and Neutropenia in Patients with Cancers
por: Anoshirvani, Ali Arash, et al.
Publicado: (2018)

Glyphosate and glyphosate-based herbicides (GBHs) induce phenotypic imipenem resistance in Pseudomonas aeruginosa
por: Háhn, Judit, et al.
Publicado: (2022)

Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-2020
por: García-Fernández, Sergio, et al.
Publicado: (2023)

1080. Relebactam Increases Imipenem Activity Against Imipenem-Nonsusceptible and -Susceptible Pseudomonas aeruginosa and Enterobacterales: Assessment of Isolates from RESTORE-IMI 2
por: Hilbert, David W, et al.
Publicado: (2021)

Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant Pseudomonas aeruginosa
por: Nasomsong, Worapong, et al.
Publicado: (2022)

In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy?
por: Cuba, Gabriel T., et al.
Publicado: (2022)

Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay
por: Portell-Buj, Elena, et al.
Publicado: (2021)

Imipenem-Cilastatin versus Sulbactam-Cefoperazone plus Amikacin in the Initial Treatment of Febrile Neutropenic Cancer Patients
por: ÖZYILKAN, Özgür, et al.
Publicado: (1999)

Prevalence and Some Possible Mechanisms of Colistin Resistance Among Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa
por: Abd El-Baky, Rehab M, et al.
Publicado: (2020)

Metallo‐beta‐lactamases among imipenem‐resistant Pseudomonas aeruginosa in a brazilian university hospital
por: Franco, Maria Renata Gomes, et al.
Publicado: (2010)

Class 1 integron and Imipenem Resistance in Clinical Isolates of Pseudomonas aeruginosa: Prevalence and Antibiotic Susceptibility
por: Yousefi, S, et al.
Publicado: (2010)

Role of Imipenem-resistant metallo-beta-lactamase positive pseudomonas aeruginosa carriers in nosocomial infections
por: Yogeesha, Babu K. V., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mktb316nm4kg36iebv1oe0nfrk